{
    "paper_id": "PMC7093856",
    "metadata": {
        "title": "Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know",
        "authors": [
            {
                "first": "Sonja",
                "middle": [
                    "A."
                ],
                "last": "Rasmussen",
                "suffix": "",
                "email": "skr9@ufl.edu",
                "affiliation": {}
            },
            {
                "first": "John",
                "middle": [
                    "C."
                ],
                "last": "Smulian",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "John",
                "middle": [
                    "A."
                ],
                "last": "Lednicky",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Tony",
                "middle": [
                    "S."
                ],
                "last": "Wen",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Denise",
                "middle": [
                    "J."
                ],
                "last": "Jamieson",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Severe acute respiratory syndrome (SARS) is caused by the SARS-CoV. Reports of the emergence of SARS-CoV appeared in February 2003, with the first cases observed in Guangdong Province in China. The virus spread to nearly 30 countries throughout the world, resulting in more than 8000 cases and 770 deaths.8\n",
            "cite_spans": [
                {
                    "start": 305,
                    "end": 306,
                    "mention": "8",
                    "ref_id": "BIBREF52"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "The outbreak was brought under control after public health control measures to reduce contact with infected persons were put into place, and no cases have been seen since 2004. Manifestations of SARS consist of fever, chills, headache, malaise, and myalgia. Diarrhea was seen in some patients. Pneumonia was nearly always seen in patients diagnosed with SARS, with mechanical ventilation being required in 10\u201320% of cases. Case fatality rate was estimated at 9\u201310% (Table\n).",
            "cite_spans": [],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": [
                {
                    "start": 466,
                    "end": 471,
                    "mention": "Table",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "The natural reservoir for SARS-CoV is believed to be bats; however, some evidence supported civet cats or raccoon dogs as possible intermediate sources of these illnesses.8 SARS is transmitted by close person-to-person contact through contact of the mucus membranes of the respiratory tract with respiratory droplets formed when an infected person coughs or sneezes. Fecal-oral transmission and transmission via fomites have also been reported.8 Airborne spread because of inhalation of small particle aerosols may also be possible.",
            "cite_spans": [
                {
                    "start": 171,
                    "end": 172,
                    "mention": "8",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 444,
                    "end": 445,
                    "mention": "8",
                    "ref_id": "BIBREF52"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Transmission in health care settings was frequently seen during the 2003 outbreak, with superspreading (when a single patient transmits infection to a disproportionate number of contacts) reported.9 The incubation period was estimated at a mean of 4.6 days, with a range of 2\u201314 days. Transmission appeared to occur most often during the second week of illness when viral excretion is highest; there is no evidence that a person with SARS is contagious before symptom onset.",
            "cite_spans": [
                {
                    "start": 197,
                    "end": 198,
                    "mention": "9",
                    "ref_id": "BIBREF53"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "The largest case series of pregnant women with SARS was from the 2003 outbreak in Hong Kong, in which 12 pregnant women were identified.10 The case-fatality rate was 25% (3 deaths). Clinical and laboratory findings were similar to those seen in the nonpregnant population. Pneumonia on chest radiograph or computed tomography was seen in all patients. Major medical complications included adult respiratory distress syndrome in 4, disseminated intravascular coagulopathy (DIC) in 3, renal failure in 3, secondary bacterial pneumonia in 2, and sepsis in 2 patients.",
            "cite_spans": [
                {
                    "start": 136,
                    "end": 138,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Pregnancy outcomes varied by trimester of presentation.10 Among the 7 women who became ill in the first trimester, 4 had a spontaneous abortion, 2 had pregnancy terminations for social reasons after recovery from SARS, and 1 delivered a full-term healthy infant. Among the 5 women who presented after 24 weeks\u2019 gestation, 4 delivered preterm. Three women delivered by cesarean delivery because of deteriorating maternal condition from their SARS illness at 26, 28, and 32 weeks\u2019 gestation.11 These babies had birthweights appropriate for gestational age. Two of the infants had respiratory distress syndrome requiring surfactant (born at 26 and 28 weeks\u2019 gestation), with one later developing bronchopulmonary dysplasia.",
            "cite_spans": [
                {
                    "start": 55,
                    "end": 57,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 489,
                    "end": 491,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Gastrointestinal complications were observed in 2 infants, including a jejunal perforation in an infant delivered at 26 weeks and necrotizing enterocolitis with ileal perforation in an infant delivered at 28 weeks\u2019 gestation. Whether these gastrointestinal complications were related to complications from SARS or its treatment or whether they were secondary to preterm delivery is unknown.11 The two infants who were delivered after their mothers\u2019 recovery from SARS had intrauterine growth restriction. No clinical, radiologic, or laboratory evidence for transmission from mother to fetus was observed, despite laboratory testing of different specimens.12\n,\n13\n",
            "cite_spans": [
                {
                    "start": 390,
                    "end": 392,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 655,
                    "end": 657,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 660,
                    "end": 662,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "A matched case-control study14 compared 10 of the 12 pregnant women noted in the previous text (2 were excluded because they were unable to be matched) with 40 nonpregnant women with SARS. Women were matched on sex, age, timing of contracting SARS, health care worker status, underlying illness, and whether the woman resided in a housing area in which there was a large outbreak.",
            "cite_spans": [
                {
                    "start": 28,
                    "end": 30,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Pregnancy appeared to have no effect on clinical symptoms or time to presentation after symptom onset. However, complications and adverse outcomes were more common among pregnant women: women who were pregnant had a longer hospital stay, were statistically significantly more likely to develop renal failure, sepsis, and DIC, and were more likely to require intensive care unit admission. Forty percent of pregnant women required mechanical ventilation, compared with 13% of nonpregnant patients (P = .07). Pregnant women were also significantly more likely to die (P = .01).",
            "cite_spans": [],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "We identified 5 reports of additional cases of SARS during pregnancy treated in Hong Kong (n = 2), the United States (n = 2), and Canada (n = 1).15, 16, 17, 18, 19 Two of the 5 women required mechanical ventilation, 1 required hemodialysis for acute renal failure, and 1 had seizures and positive cerebrospinal fluid for SARS-CoV, suggestive of a central nervous system infection. All patients recovered from their illness. In 1 case, the pregnancy was terminated at the mother\u2019s request; the remaining pregnancies ended in liveborn infants (2 at term and 2 preterm). Testing of neonatal specimens for SARS-CoV RNA was negative.",
            "cite_spans": [
                {
                    "start": 145,
                    "end": 147,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 149,
                    "end": 151,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 153,
                    "end": 155,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 157,
                    "end": 159,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 161,
                    "end": 163,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Several hospitals in Toronto and Hong Kong reported measures instituted on obstetrics services during the SARS outbreak to decrease transmission to pregnant women, their families, community members, and health care workers.20\n,\n21 For example, all hospital staff, patients, and visitors were screened for symptoms at the hospital entrance and wore N95 respirators. Visitors were limited to 1 per patient on labor and delivery, with no visitors allowed in the postpartum ward.",
            "cite_spans": [
                {
                    "start": 223,
                    "end": 225,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 228,
                    "end": 230,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Postpartum stays were reduced in length with a postpartum nurse home visit added. Postpartum patients were asked to observe a 10 day home quarantine. Health care workers were asked to observe a work quarantine in which they were asked to go directly from home to work and vice versa to minimize interaction in the community. Obstetric services considered to be nonessential such as routine ultrasound and prenatal diagnosis were suspended. Although the impact of these interventions was not evaluated, there may be some relevant lessons learned from these experiences during SARS that could help inform the approach to COVID-19.",
            "cite_spans": [],
            "section": "SARS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Middle East Respiratory Syndrome (MERS) is a respiratory illness caused by MERS-CoV. The illness was first identified in Saudi Arabia in 2012, with spread to other countries in the Arabian peninsula and eventually to countries outside the Arabian peninsula, including the United States.22\n,\n23 The largest outbreak outside the Arabian Peninsula was in the Republic of Korea in 2015.",
            "cite_spans": [
                {
                    "start": 286,
                    "end": 288,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 291,
                    "end": 293,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "MERS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Nearly 2500 cases of MERS-CoV illness and more than 860 deaths have been reported with continuing reports into the present. The manifestations of MERS include severe respiratory illness characterized by fever, cough, and shortness of breath. Some patients also have diarrhea. The case fatality rate is estimated to be 35\u201340%.",
            "cite_spans": [],
            "section": "MERS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Patients who developed MERS were more likely to be older (median age is 50 years) with about two thirds of patients being male. Patients with MERS were also more likely to have an underlying illness. Some patients with MERS-CoV infection have been asymptomatic (identified through contact investigations).",
            "cite_spans": [],
            "section": "MERS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "The mean incubation period is 5.2 days, with a range of 2\u201313 days. As with SARS, MERS is mainly spread person to person through close contact, with transmission in health care settings, and superspreading events have been observed. However, since 2016, the number of cases of MERS-CoV has been dramatically reduced after public health efforts to prevent MERS-CoV transmission were put into place.24\n",
            "cite_spans": [
                {
                    "start": 396,
                    "end": 398,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "MERS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Information on MERS among pregnant women is limited. We identified reports of 13 cases of pregnant women with MERS from several countries, including Saudi Arabia (n = 8), Korea (n = 2), Jordan (n = 1), United Arab Emirates (n = 1), and Philippines (n = 1).13\n,\n25, 26, 27, 28, 29, 30, 31 Two women were asymptomatic, identified as part of a contact investigation. Among the 11 symptomatic women, manifestations were similar to those seen in nonpregnant patients with MERS.",
            "cite_spans": [
                {
                    "start": 256,
                    "end": 258,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 261,
                    "end": 263,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 265,
                    "end": 267,
                    "mention": "26",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 269,
                    "end": 271,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 273,
                    "end": 275,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 277,
                    "end": 279,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 281,
                    "end": 283,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 285,
                    "end": 287,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "MERS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Seven of 13 patients were admitted to an intensive care unit for respiratory deterioration or acute respiratory distress syndrome, 5 required ventilator support, 3 died, and 8 recovered. Among the 3 deaths, the mothers died 8\u201325 days after delivery. Both babies born to asymptomatic women were born healthy at term; among those who were symptomatic, there was 1 intrauterine fetal demise, 1 stillbirth, 1 baby delivered at 25 weeks who died 4 hours after birth, 2 healthy preterm infants, and 5 healthy term infants (infant status was not mentioned for 1).",
            "cite_spans": [],
            "section": "MERS and its effects on pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Respiratory illness caused by a novel coronavirus (now referred to as SARS-CoV-2) was first noted in December 2019 in Wuhan, Hubei Province, China. The WHO China Country office was notified of an outbreak of pneumonia of unknown etiology on Dec. 31, 2019 (Figure 2). Between Dec. 31, 2019, and Jan. 3, 2020, 44 cases were reported to the WHO. On Jan. 7, 2020, Chinese authorities identified a novel coronavirus as the cause. The virus has quickly spread first through Wuhan and subsequently to other areas of China and other countries in the world (Figure 1).",
            "cite_spans": [],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": [
                {
                    "start": 256,
                    "end": 264,
                    "mention": "Figure 2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 549,
                    "end": 557,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Early data suggested an association between the Huanan Seafood Wholesale Market and COVID-19 with 27 of 41 cases in 1 report32 and 26 of 47 in another report33 with epidemiologic links to the market, leading to closure of the market on Jan. 1, 2020. Given that the earliest case reported (illness onset on Dec. 1, 2019)32 did not have exposure to the market raises the possibility that the initial emergence into humans occurred elsewhere. However, sampling of the market\u2019s environment supports the market\u2019s importance in early transmission of the virus. Later cases were much less likely to have visited the market, supporting the role of person-to-person transmission in later cases.",
            "cite_spans": [
                {
                    "start": 124,
                    "end": 126,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 157,
                    "end": 159,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 319,
                    "end": 321,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "The SARS-CoV-2 is a betacoronavirus similar to SARS-CoV and MERS-CoV (Table). Sequencing data show that the SARS-CoV-2 is most closely related to coronaviruses found in bats, with more than 85% nucleotide identity with a bat SARS-like CoV.34\n,\n35 The virus has 79% nucleotide identity to SARS-CoV and about 50% to MERS-CoV.35\n",
            "cite_spans": [
                {
                    "start": 239,
                    "end": 241,
                    "mention": "34",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 244,
                    "end": 246,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 323,
                    "end": 325,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": [
                {
                    "start": 70,
                    "end": 75,
                    "mention": "Table",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Bats appear to be the natural reservoirs of both SARS-CoV and MERS-CoV. The emergence of these viruses in humans has been attributed to host switching: the virus jumped from an intermediary host species (eg, civet cats for SARS-CoV and dromedary camels for MERS-CoV) to humans. An intermediary host species is thought to be likely for SARS-CoV-2,35 although it has been yet to be identified. Sequence data show a high degree (>99.98%) of similarity of the virus among different patients, suggesting a recent emergence in humans.",
            "cite_spans": [
                {
                    "start": 346,
                    "end": 348,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Clinical manifestations of COVID-19 are similar to those with SARS and MERS (Table). Studies of hospitalized patients with COVID-19 show that patients commonly develop severe pneumonia, with 23\u201332% admitted to the intensive care unit and 17\u201329% of cases progressing to acute respiratory distress syndrome. 32\n,\n36\n,\n37 Among hospitalized patients, 4\u201315% have died.32\n,\n36\n,\n37 Overall case fatality ratio estimates (including asymptomatic and symptomatic infections) appear to be in the range of 1% (95% confidence interval, 0.5\u20134%),38 although these estimates should be considered preliminary.",
            "cite_spans": [
                {
                    "start": 306,
                    "end": 308,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 311,
                    "end": 313,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 316,
                    "end": 318,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 364,
                    "end": 366,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 369,
                    "end": 371,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 374,
                    "end": 376,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 533,
                    "end": 535,
                    "mention": "38",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": [
                {
                    "start": 77,
                    "end": 82,
                    "mention": "Table",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Average age of hospitalized patients was 49\u201356 years, with 32\u201351% having an underlying illness. Most patients (54\u201373%) were men. Children with COVID-19 appear to be rarely identified, with only 28 children reported as of Jan. 30, 2020 (<1% of total), and most of those identified had mild symptoms.39 No pregnant women were reported in any of these initial cohorts. Common manifestations among hospitalized patients were fever (83\u2013100%), cough (59\u201382%), myalgia (11\u201335%), headache (7\u20138%), and diarrhea (2\u201310%). All patients had abnormalities on radiographic imaging of the chest.",
            "cite_spans": [
                {
                    "start": 298,
                    "end": 300,
                    "mention": "39",
                    "ref_id": "BIBREF32"
                }
            ],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Person-to-person transmission of SARS-CoV-2 is thought to be similar to transmission of influenza and other respiratory pathogens; respiratory droplets are formed when an infected person coughs or sneezes and these droplets are inhaled by close contacts, generally within 6 feet. It is unclear whether infection can be transmitted from fomites. Fecal-oral transmission might be possible, given that SARS-CoV-2 has been identified in stool specimens40 and SARS-CoV might have been transmitted in this manner.41\n",
            "cite_spans": [
                {
                    "start": 448,
                    "end": 450,
                    "mention": "40",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 507,
                    "end": 509,
                    "mention": "41",
                    "ref_id": "BIBREF35"
                }
            ],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "The basic reproduction number, R0 (the average number of people who will become infected from a single infected person in a population in which all persons are susceptible) is affected by factors such as the duration of infectivity, the transmissibility of the pathogen, and the number of susceptible contacts. Measles, which is highly infective, has an R0 of 12\u201318, while 2009 H1N1 influenza and SARS have an R0 of 1.2\u20131.6 and 2\u20135, respectively.42 Current estimates of R0 for SARS-CoV-2 places it at 2.2 (95% confidence interval, 1.4\u20133.9)33 As with SARS and MERS, nosocomial transmission is playing a key role in transmission, presumed to be responsible for infection of 29% of affected health professionals and 12% of hospitalized patients in a recent study.37\n",
            "cite_spans": [
                {
                    "start": 446,
                    "end": 448,
                    "mention": "42",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 539,
                    "end": 541,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 760,
                    "end": 762,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Clinical, epidemiologic, and viral characteristics ::: Coronavirus disease 2019 (COVID-19) ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Although data are limited, there is no evidence from other severe coronavirus infections (SARS or MERS) that pregnant women are more susceptible to infection with coronavirus. Thus far, in this outbreak of novel coronavirus infection, more men have been affected than women.32\n,\n33\n,\n36\n,\n37 This observed gender difference could be due to differences in reporting, susceptibility, exposure, or recognition and diagnosis of infection. There are no data to inform whether pregnancy increases susceptibility to COVID-19.",
            "cite_spans": [
                {
                    "start": 274,
                    "end": 276,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 279,
                    "end": 281,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 284,
                    "end": 286,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 289,
                    "end": 291,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Susceptibility to and severity of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Previous data on SARS and MERS suggest that clinical findings during pregnancy can range from no symptoms to severe disease and death. The most common symptoms of COVID-19 are fever and cough, with more than 80% of hospitalized patients presenting with these symptoms.36\n",
            "cite_spans": [
                {
                    "start": 268,
                    "end": 270,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Susceptibility to and severity of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "In a recent study by Chen et al,44 9 women diagnosed with COVID-19 during the third trimester of pregnancy were reported. In this small series, clinical presentation was similar to that seen in nonpregnant adults, with fever in 7, cough in 4, myalgia in 3, and sore throat and malaise each in 2 women. Five had lymphopenia. All had pneumonia, but none required mechanical ventilation, and none died. All women had a cesarean delivery, and Apgar scores were 8\u20139 at 1 minute and 9\u201310 at 5 minutes.",
            "cite_spans": [
                {
                    "start": 32,
                    "end": 34,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                }
            ],
            "section": "Susceptibility to and severity of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "In a second series of 9 pregnancies with 10 infants (1 set of twins) reported by Zhu et al.,45 symptom onset was before delivery (1\u20136 days) in 4, on the day of delivery in 2, and after delivery (1\u20133 days) in 3 cases. Clinical presentation of COVID-19 was similar to that seen in nonpregnant patients. Among the 9 pregnancies, intrauterine fetal distress was noted in 6, 7 were cesarean deliveries, and 6 infants were born preterm. Based on these limited reports and the available data from other respiratory pathogens such as SARS and influenza, it is unknown whether pregnant women with COVID-19 will experience more severe disease.",
            "cite_spans": [
                {
                    "start": 92,
                    "end": 94,
                    "mention": "45",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "Susceptibility to and severity of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Travel recommendations have been instituted to limit exposure to persons in the United States. All persons, including pregnant women, should not travel to China. On Feb. 2, 2020, the US State Department upgraded their travel advisory to level 4, the highest level of travel advisory. Obstetric providers should obtain a detailed travel history for all patients and should specifically ask about travel in the past 14 days to areas experiencing widespread transmission of SARS-CoV-2. Currently this is limited to China, but this situation is rapidly evolving and obstetricians should stay alert to the global situation by consulting the Centers for Disease Control and Prevention website and following media coverage.",
            "cite_spans": [],
            "section": "Travel guidance for pregnant women ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "There is currently no vaccine to prevent COVID-19. Since posting of a SARS-CoV-2 virus genetic sequence online on Jan. 10, 2020, multiple organizations, including the National Institutes of Health, have been working to rapidly develop a COVID-19 vaccine. Development of this vaccine builds on and benefits from work on SARS and MERS vaccines.46 However, it is not known how quickly a safe and effective vaccine may be readily available.",
            "cite_spans": [
                {
                    "start": 342,
                    "end": 344,
                    "mention": "46",
                    "ref_id": "BIBREF40"
                }
            ],
            "section": "Vaccination in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "All patients, including pregnant women, should be evaluated for fever and signs and symptoms of a respiratory infection. Ideally, screening procedures begin before arrival on a labor and delivery unit or prenatal care clinic. For example, when scheduling appointments, patients should be instructed what to do if they have respiratory symptoms on the day of their appointment, or if a patient calls triage prior to presentation, respiratory signs and symptoms should be assessed over the telephone.",
            "cite_spans": [],
            "section": "Infection control measures and diagnostic testing ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Those patients with respiratory symptoms should be separated from other waiting patients and a facemask should be placed on them. Patients who meet criteria for a person under investigation (Box 1\n) should be immediately placed in an airborne infection isolation room (single-patient rooms at negative pressure). Once in isolation, the patient\u2019s facemask may be removed. Health care personnel should adhere to standard, contact, and airborne precautions. Infection control personnel and local/state health departments should be notified immediately; local/state health departments can help to arrange testing of relevant specimens (upper and lower respiratory specimens and serum are currently recommended; other specimens [stool and urine] may also be sent).\n\n",
            "cite_spans": [],
            "section": "Infection control measures and diagnostic testing ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "General principles regarding management of COVID-10 during pregnancy include early isolation, aggressive infection control procedures, testing for SARS-CoV-2 and coinfection, oxygen therapy as needed, avoidance of fluid overload, empiric antibiotics (because of secondary bacterial infection risk), fetal and uterine contraction monitoring, early mechanical ventilation for progressive respiratory failure, individualized delivery planning, and a team-based approach with multispecialty consultations (Box 2\n).\n\n",
            "cite_spans": [],
            "section": "Management of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Team-based management is recommended for pregnancies managed in a health care facility and should include a determination of the optimal clinical unit on which to provide care. Ability to provide surveillance for early detection of a worsening maternal course of illness, as well as an ability to monitor for evidence of obstetric complications (eg, preterm labor or fetal compromise), are needed.",
            "cite_spans": [],
            "section": "Management of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Changes in fetal heart rate pattern may be an early indicator of maternal respiratory deterioration. Based on experience with SARS and MERS, severe respiratory failure might occur in pregnant women, and in the most severe cases, mechanical ventilation might not be sufficient to support adequate oxygenation. If that occurs, limited literature suggests a potential role of extracorporeal membrane oxygenation in pregnancy; use should be considered only in centers that have experience with this technique.47 Whether delivery provides benefit to a critically ill mother is unknown; decisions regarding delivery should consider the gestational age of the fetus and should be made in conjunction with the neonatologist.48\n",
            "cite_spans": [
                {
                    "start": 505,
                    "end": 507,
                    "mention": "47",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 716,
                    "end": 718,
                    "mention": "48",
                    "ref_id": "BIBREF42"
                }
            ],
            "section": "Management of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "There are currently no antiviral medications approved by the US Food and Drug Administration for treatment of COVID-19, although broad-spectrum antivirals used in animal models of MERS are being evaluated for activity against SARS-CoV-2.46 Corticosteroids for the treatment of coronavirus-associated pneumonia should be avoided unless other indications are present because they were not shown to be beneficial in MERS and could lead to delayed MERS-CoV clearance.49 Therefore, decisions about the use of corticosteroids for fetal lung maturity should be made in consultation with infectious disease specialists and maternal-fetal medicine consultants. All guidance should be considered subject to revision as additional data on pregnant women with COVID-19 become available.",
            "cite_spans": [
                {
                    "start": 237,
                    "end": 239,
                    "mention": "46",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 463,
                    "end": 465,
                    "mention": "49",
                    "ref_id": "BIBREF43"
                }
            ],
            "section": "Management of COVID-19 in pregnancy ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Although the limited experience with newborn evaluations after delivery with SARS and MERS has not identified cases of maternal-to-fetal transmission, reports have appeared in the media of a 30 hour infant who was diagnosed with COVID-19, suggesting the possibility of in utero transmission.50 However, insufficient information is included in media reports to rule out perinatal or postnatal modes of transmission.",
            "cite_spans": [
                {
                    "start": 291,
                    "end": 293,
                    "mention": "50",
                    "ref_id": "BIBREF45"
                }
            ],
            "section": "Care of infants born to mothers with COVID-19 ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Data from the recent case series published by Chen et al44 and Zhu et al45 of 18 women (19 infants) infected in the third trimester of pregnancy with SARS-CoV-2 identified no laboratory evidence of vertical transmission. Testing of amniotic fluid, cord blood, and neonatal throat swab samples was negative for SARS-CoV-2 in the 6 patients reported by Chen et al.44\n",
            "cite_spans": [
                {
                    "start": 56,
                    "end": 58,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 72,
                    "end": 74,
                    "mention": "45",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 362,
                    "end": 364,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                }
            ],
            "section": "Care of infants born to mothers with COVID-19 ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "In the report by Zhu et al.,45 some infants were symptomatic (shortness of breath in 6, cyanosis in 3, gastric bleeding in 2, and 1 baby died of multiple organ failure and DIC); however, throat swab testing of all infants was negative for SARS-CoV-2 , suggesting that these neonatal complications might not be related intrauterine transmission. Thus, at this time, it is unknown whether SARS-CoV-2 can be transmitted from mother-to-fetus.",
            "cite_spans": [
                {
                    "start": 28,
                    "end": 30,
                    "mention": "45",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "Care of infants born to mothers with COVID-19 ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Given the current lack of information, it seems reasonable to assume that a newborn born to a mother with COVID-19 at delivery could possibly be infected, either in utero or perinatally, and thus should be placed in isolation to avoid exposure to other newborns. Although the ideal setting for a healthy infant is within a healthy mother\u2019s room, temporary separation of an ill mother and her infant, as was recommended during pandemic H1N1,51 seems prudent.",
            "cite_spans": [
                {
                    "start": 440,
                    "end": 442,
                    "mention": "51",
                    "ref_id": "BIBREF46"
                }
            ],
            "section": "Care of infants born to mothers with COVID-19 ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Whether COVID-19 can be transmitted through breastmilk is unknown. We are aware of a single report of SARS-CoV testing of breastmilk in a mother who had recovered from SARS and no viral RNA was detected; however, the specimen was collected \u223c130 days after illness onset.15 SARS-CoV antibodies were seen in breastmilk of that patient15 but not in another patient who was infected at 7 weeks\u2019 gestation with breastmilk tested at postpartum days 12 and 30.16 Breastmilk was tested for SARS-CoV-2 in 6 of the mothers reported by Chen et al44; all specimens were negative.",
            "cite_spans": [
                {
                    "start": 270,
                    "end": 272,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 332,
                    "end": 334,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 453,
                    "end": 455,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 535,
                    "end": 537,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                }
            ],
            "section": "Care of infants born to mothers with COVID-19 ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "Until additional data are available, mothers who intend to breastfeed and are well enough to express breastmilk should be encouraged to do so; breastfeeding can be instituted after she is no longer considered infectious. No data are available to guide length of separation and will need to be decided on a case-by-case basis after discussion between infection control experts and neonatologists.",
            "cite_spans": [],
            "section": "Care of infants born to mothers with COVID-19 ::: Implications of COVID-19 for pregnant women ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "The COVID-19 outbreak is rapidly increasing in the number of cases, deaths, and countries affected. Much is unknown about the virus and its effects, including its modes of transmission, the basic reproduction number, risk factors for illness, and case fatality rate. Although cases are primarily in China, it is highly likely that there will be additional global spread of the virus.",
            "cite_spans": [],
            "section": "Conclusions ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "At the present time, limited data are available on pregnant women with COVID-19 on which to base recommendations for pregnancy-specific care; however, early reports and lessons from SARS, MERS, and other respiratory infections suggest that pregnant women could have a severe clinical course. Surveillance systems for cases of COVID-19 need to include information on pregnancy status as well as maternal and fetal outcomes.",
            "cite_spans": [],
            "section": "Conclusions ::: SARS and its effects on pregnant women",
            "ref_spans": []
        },
        {
            "text": "It is important to be vigilant about the spread of the disease and be able to provide rapid implementation of outbreak control and management measures once the virus reaches a community. Standard interventions to manage any severe respiratory infection is the foundation of care for any pregnant woman with COVID-19 and should be implemented aggressively in a team-based care model.",
            "cite_spans": [],
            "section": "Conclusions ::: SARS and its effects on pregnant women",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table: Comparison of characteristics of SARS, MERS, and COVID-19a\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Box 1: Criteria to guide evaluation of persons under investigation for COVID-19\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Box 2: Principles for management of pregnant women with confirmed or suspected COVID-1948,53,54,a\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure\u00a01: Global map of confirmed COVID-19 cases Global map of confirmed COVID-19 cases (as of Feb. 14, 2020) (from https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html). COVID-19, coronavirus disease 2019. Rasmussen. 2019 novel coronavirus and pregnancy. Am J Obstet Gynecol 2020.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure\u00a02: Timeline showing key events in the COVID-19 outbreak Timeline showing key events in the COVID-19 outbreak, Dec. 1, 2019, through Feb. 15, 2020. CDC, Centers for Disease Control and Prevention; COVID-19, coronavirus disease 2019; US, United States; WHO, World Health Organization. Rasmussen. 2019 novel coronavirus and pregnancy. Am J Obstet Gynecol 2020.",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure\u00a03: Illustration of the causative virion for COVID-19 Reproduced, with permission, from the Centers for Disease Control and Prevention/Alissa Eckert, MS (obtained from the CDC\u2019s Public Health Image Library; https://phil.cdc.gov/Details.aspx?pid=23312). COVID-19, coronavirus disease 2019. Rasmussen. 2019 novel coronavirus and pregnancy. Am J Obstet Gynecol 2020.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Public health approach to emerging infections among pregnant women",
            "authors": [
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "E.B.",
                    "middle": [],
                    "last": "Hayes",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Am J Public Health",
            "volume": "95",
            "issn": "",
            "pages": "1942-1944",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "S.F.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "Chow",
                    "suffix": ""
                },
                {
                    "first": "T.N.",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Am J Obstet Gynecol",
            "volume": "191",
            "issn": "",
            "pages": "292-297",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Infants born to mothers with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "C.C.",
                    "middle": [],
                    "last": "Shek",
                    "suffix": ""
                },
                {
                    "first": "P.C.",
                    "middle": [],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "G.P.",
                    "middle": [],
                    "last": "Fung",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Pediatrics",
            "volume": "112",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "SARS in newborns and children",
            "authors": [
                {
                    "first": "P.C.",
                    "middle": [],
                    "last": "Ng",
                    "suffix": ""
                },
                {
                    "first": "C.W.",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "W.K.",
                    "middle": [],
                    "last": "Chiu",
                    "suffix": ""
                },
                {
                    "first": "S.F.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "E.K.",
                    "middle": [],
                    "last": "Hon",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Biol Neonate",
            "volume": "85",
            "issn": "",
            "pages": "293-298",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Emergency cesarean section in an epidemic of the middle east respiratory syndrome: a case report",
            "authors": [
                {
                    "first": "M.H.",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                },
                {
                    "first": "H.R.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "D.H.",
                    "middle": [],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Sung",
                    "suffix": ""
                },
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Korean J Anesthesiol",
            "volume": "69",
            "issn": "",
            "pages": "287-291",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "A\u00a0case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Lam",
                    "suffix": ""
                },
                {
                    "first": "S.F.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "T.N.",
                    "middle": [],
                    "last": "Leung",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "BJOG",
            "volume": "111",
            "issn": "",
            "pages": "771-774",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "SARS and pregnancy: a case report",
            "authors": [
                {
                    "first": "C.A.",
                    "middle": [],
                    "last": "Robertson",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Lowther",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Birch",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Emerg Infect Dis",
            "volume": "10",
            "issn": "",
            "pages": "345-348",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "SARS during pregnancy, United States",
            "authors": [
                {
                    "first": "L.J.",
                    "middle": [],
                    "last": "Stockman",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Lowther",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Coy",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Saw",
                    "suffix": ""
                },
                {
                    "first": "U.D.",
                    "middle": [],
                    "last": "Parashar",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Emerg Infect Dis",
            "volume": "10",
            "issn": "",
            "pages": "1689-1690",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Severe acute respiratory syndrome in pregnancy",
            "authors": [
                {
                    "first": "M.H.",
                    "middle": [],
                    "last": "Yudin",
                    "suffix": ""
                },
                {
                    "first": "D.M.",
                    "middle": [],
                    "last": "Steele",
                    "suffix": ""
                },
                {
                    "first": "M.D.",
                    "middle": [],
                    "last": "Sgro",
                    "suffix": ""
                },
                {
                    "first": "S.E.",
                    "middle": [],
                    "last": "Read",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Kopplin",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Gough",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Obstet Gynecol",
            "volume": "105",
            "issn": "",
            "pages": "124-127",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Specific immunoglobulin g antibody detected in umbilical blood and amniotic fluid from a pregnant woman infected by the coronavirus associated with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Clin Diagn Lab Immunol",
            "volume": "11",
            "issn": "",
            "pages": "1182-1184",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Possible central nervous system infection by SARS coronavirus",
            "authors": [
                {
                    "first": "K.K.",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "W.C.",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "C.M.",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "S.T.",
                    "middle": [],
                    "last": "Lau",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Sheng",
                    "suffix": ""
                },
                {
                    "first": "K.Y.",
                    "middle": [],
                    "last": "Yuen",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Emerg Infect Dis",
            "volume": "10",
            "issn": "",
            "pages": "342-344",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States",
            "authors": [
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Siston",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Honein",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "JAMA",
            "volume": "303",
            "issn": "",
            "pages": "1517-1525",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "The effect of Severe Acute Respiratory Syndrome on a hospital obstetrics and gynaecology service",
            "authors": [
                {
                    "first": "C.J.",
                    "middle": [],
                    "last": "Haines",
                    "suffix": ""
                },
                {
                    "first": "Y.W.",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "T.K.",
                    "middle": [],
                    "last": "Chung",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "BJOG",
            "volume": "110",
            "issn": "",
            "pages": "643-645",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Managing obstetrical patients during severe acute respiratory syndrome outbreak",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Owolabi",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Kwolek",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J\u00a0Obstet Gynaecol Can",
            "volume": "26",
            "issn": "",
            "pages": "35-41",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities, May 2014",
            "authors": [
                {
                    "first": "S.R.",
                    "middle": [],
                    "last": "Bialek",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Allen",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Alvarado-Ramy",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "63",
            "issn": "",
            "pages": "431-436",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Middle East respiratory syndrome (MERS)",
            "authors": [
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "A.K.",
                    "middle": [],
                    "last": "Watson",
                    "suffix": ""
                },
                {
                    "first": "D.L.",
                    "middle": [],
                    "last": "Swerdlow",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Microbiol Spectr",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Worldwide reduction in MERS cases and deaths since 2016",
            "authors": [
                {
                    "first": "C.A.",
                    "middle": [],
                    "last": "Donnelly",
                    "suffix": ""
                },
                {
                    "first": "M.R.",
                    "middle": [],
                    "last": "Malik",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Elkholy",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Cauchemez",
                    "suffix": ""
                },
                {
                    "first": "M.D.",
                    "middle": [],
                    "last": "Van Kerkhove",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Emerg Infect Dis",
            "volume": "25",
            "issn": "",
            "pages": "1758-1760",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature",
            "authors": [
                {
                    "first": "S.H.",
                    "middle": [],
                    "last": "Alfaraj",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Al-Tawfiq",
                    "suffix": ""
                },
                {
                    "first": "Z.A.",
                    "middle": [],
                    "last": "Memish",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J\u00a0Microbiol Immunol Infect",
            "volume": "52",
            "issn": "",
            "pages": "501-503",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Alserehi",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Wali",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Alshukairi",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Alraddadi",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "BMC Infect Dis",
            "volume": "16",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Assiri",
                    "suffix": ""
                },
                {
                    "first": "G.R.",
                    "middle": [],
                    "last": "Abedi",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Al Masri",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Bin Saeed",
                    "suffix": ""
                },
                {
                    "first": "S.I.",
                    "middle": [],
                    "last": "Gerber",
                    "suffix": ""
                },
                {
                    "first": "J.T.",
                    "middle": [],
                    "last": "Watson",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Clin Infect Dis",
            "volume": "63",
            "issn": "",
            "pages": "951-953",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Malik",
                    "suffix": ""
                },
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "El Masry",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Ravi",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Sayed",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Emerg Infect Dis",
            "volume": "22",
            "issn": "",
            "pages": "515-517",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Stillbirth during infection with Middle East respiratory syndrome coronavirus",
            "authors": [
                {
                    "first": "D.C.",
                    "middle": [],
                    "last": "Payne",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Iblan",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Alqasrawi",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J\u00a0Infect Dis",
            "volume": "209",
            "issn": "",
            "pages": "1870-1872",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians",
            "authors": [
                {
                    "first": "C.A.",
                    "middle": [],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "J.E.",
                    "middle": [],
                    "last": "Staples",
                    "suffix": ""
                },
                {
                    "first": "W.B.",
                    "middle": [],
                    "last": "Dobyns",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "JAMA Pediatr",
            "volume": "171",
            "issn": "",
            "pages": "288-295",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Contact tracing the first Middle East respiratory syndrome case in the Philippines, February 2015",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Racelis",
                    "suffix": ""
                },
                {
                    "first": "V.C.",
                    "middle": [],
                    "last": "de los Reyes",
                    "suffix": ""
                },
                {
                    "first": "M.N.",
                    "middle": [],
                    "last": "Sucaldito",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Deveraturda",
                    "suffix": ""
                },
                {
                    "first": "J.B.",
                    "middle": [],
                    "last": "Roca",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Tayag",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Western Pac Surveill Response J",
            "volume": "6",
            "issn": "",
            "pages": "3-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "MERS-CoV infection in a pregnant woman in Korea",
            "authors": [
                {
                    "first": "S.Y.",
                    "middle": [],
                    "last": "Jeong",
                    "suffix": ""
                },
                {
                    "first": "S.I.",
                    "middle": [],
                    "last": "Sung",
                    "suffix": ""
                },
                {
                    "first": "J.H.",
                    "middle": [],
                    "last": "Sung",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J\u00a0Korean Med Sci",
            "volume": "32",
            "issn": "",
            "pages": "1717-1720",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Report 4: severity of 2019-novel coronavirus (nCoV). WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis, Imperial College London",
            "authors": [
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Dorigatti",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Okell",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Cori",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Zika vrus and birth defects\u2014reviewing the evidence for causality",
            "authors": [
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "D.J.",
                    "middle": [],
                    "last": "Jamieson",
                    "suffix": ""
                },
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Honein",
                    "suffix": ""
                },
                {
                    "first": "L.R.",
                    "middle": [],
                    "last": "Petersen",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "N\u00a0Engl J Med",
            "volume": "374",
            "issn": "",
            "pages": "1981-1987",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "Evidence of airborne transmission of the severe acute respiratory syndrome virus",
            "authors": [
                {
                    "first": "I.T.",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "T.W.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "N\u00a0Engl J Med",
            "volume": "350",
            "issn": "",
            "pages": "1731-1739",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "Pregnant women and the Ebola crisis",
            "authors": [
                {
                    "first": "L.B.",
                    "middle": [],
                    "last": "Haddad",
                    "suffix": ""
                },
                {
                    "first": "D.J.",
                    "middle": [],
                    "last": "Jamieson",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Rasmussen",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "N\u00a0Engl J Med",
            "volume": "379",
            "issn": "",
            "pages": "2492-2493",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Extracorporeal membrane oxygenation (ECMO) during pregnancy and postpartum",
            "authors": [
                {
                    "first": "L.D.",
                    "middle": [],
                    "last": "Pacheco",
                    "suffix": ""
                },
                {
                    "first": "G.R.",
                    "middle": [],
                    "last": "Saade",
                    "suffix": ""
                },
                {
                    "first": "G.D.V.",
                    "middle": [],
                    "last": "Hankins",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Semin Perinatol",
            "volume": "42",
            "issn": "",
            "pages": "21-25",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Management of acute respiratory failure in pregnancy",
            "authors": [
                {
                    "first": "S.E.",
                    "middle": [],
                    "last": "Lapinsky",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Semin Respir Crit Care Med",
            "volume": "38",
            "issn": "",
            "pages": "201-207",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome",
            "authors": [
                {
                    "first": "Y.M.",
                    "middle": [],
                    "last": "Arabi",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Mandourah",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Al-Hameed",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Am J Respir Crit Care Med",
            "volume": "197",
            "issn": "",
            "pages": "757-767",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Can coronavirus pass from mother to baby? Maybe, but experts need more research. Global news",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "D'Amore",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns",
            "authors": [
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "D.M.",
                    "middle": [],
                    "last": "Kissin",
                    "suffix": ""
                },
                {
                    "first": "L.F.",
                    "middle": [],
                    "last": "Yeung",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Am J Obstet Gynecol",
            "volume": "204",
            "issn": "",
            "pages": "S13-S20",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "Interim infection prevention and control recommendations for patients with confirmed 2019 novel coronavirus (2019-nCoV) or patients under investigation for 2019-nCoV in healthcare settings. Centers for Disease Control and Prevention. Updated Feb. 3, 2020",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "Interim guidance for implementing home care of people not requiring hospitalization for 2019 novel coronavirus (2019-nCoV). Updated Jan. 31, 2020",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF50": {
            "title": "Coronavirus disease (COVID-19) outbreak",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "World Health Organization",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF51": {
            "title": "Severe acute respiratory syndrome-related coronavirus: the species and its viruses\u2014a statement of the Coronavirus Study Group",
            "authors": [
                {
                    "first": "A.E.",
                    "middle": [],
                    "last": "Gorbalenya",
                    "suffix": ""
                },
                {
                    "first": "S.C.",
                    "middle": [],
                    "last": "Baker",
                    "suffix": ""
                },
                {
                    "first": "R.S.",
                    "middle": [],
                    "last": "Baric",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF52": {
            "title": "Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features",
            "authors": [
                {
                    "first": "D.S.C.",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Zumla",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Infect Dis Clin North Am",
            "volume": "33",
            "issn": "",
            "pages": "869-889",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF53": {
            "title": "MERS, SARS, and Ebola: the role of super-spreaders in infectious disease",
            "authors": [
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Bi",
                    "suffix": ""
                },
                {
                    "first": "G.F.",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Cell Host Microbe",
            "volume": "18",
            "issn": "",
            "pages": "398-401",
            "other_ids": {
                "DOI": []
            }
        }
    }
}